# Postoperative symptomatic vasospasm in pituitary surgery: case series and systematic review – a matter of blood?

**Authors:** Lennart W. Sannwald, Gregor Durner, Hans-Georg M. Kesseler, Nina Kreße, Michal Hlavac, Andreas Knoll, Johannes Roßkopf, Ralph W. König, Christian R. Wirtz, Andrej Pala

PMC · DOI: 10.1007/s10143-026-04182-4 · Neurosurgical Review · 2026-02-19

## TL;DR

This paper reviews cases of rare but severe vasospasm after pituitary surgery, linking it to tumor bed hemorrhage and suggesting the need for better monitoring and treatment.

## Contribution

The study provides a systematic review and case series highlighting the association between vasospasm after pituitary surgery and tumor bed hemorrhage.

## Key findings

- Vasospasm after pituitary surgery is rare but often leads to severe neurological outcomes.
- Tumor bed hemorrhage is present in 75% of cases with early postoperative imaging.
- Vasospasm is most commonly associated with large non-functioning pituitary adenomas or craniopharyngiomas.

## Abstract

Vasospasm is an unusual complication after pituitary surgery with potentially severe sequelae. There is limited information available in the literature concerning risk, patterns, outcomes and therapy. This systematic review investigates reported cases between 1956 and 2025 to improve assessment and management of this phenomenon. Pubmed database was systematically screened between 1st January 1969 and 10th October 2025 for medical subject headings (MeSH-terms) ‘Vasospasm’ OR ‘Delayed cerebral ischemia’ OR ‘Delayed neurological deficit’ AND ‘pituitary surgery’. The first description by Krayenbühl in 1956 was included as only report that could be identified before 1969. Overall, 262 articles were identified and abstracts screened. Afterwards, 59 articles were reviewed identifying 114 patients and excluding 205 patients. Additionally, three original cases are reported. Vasospasm after pituitary surgery is most often reported after resection of large non-functioning pituitary adenomas (50/117) or craniopharyngiomas (25/117). Vasospasm manifests predominantly between the fifth and twelfth postoperative day (73%) with altered sensorium, palsy or aphasia and affects ICA, MCA, ACA or their combinations in more than 90% of cases. Tumor bed hemorrhage was present in 75% of cases with reported early postoperative MR or CT imaging. Therapy is not standardized, more than half of reported patients suffer permanent neurological morbidity (36.7%) or mortality (19.4%). Vasospasm after pituitary surgery is rare but devastating in an otherwise benign disease. This systematic review suggests an association with tumor bed hemorrhage and marked similarities with subarachnoid hemorrhage induced vasospasm. Patients at risk should be defined preoperatively and closely monitored postoperatively.

## Linked entities

- **Diseases:** subarachnoid hemorrhage (MONDO:0005099)

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}
- **Diseases:** palsy (MESH:D010243), adenoma (MESH:D000236), MES (MESH:C536133), hyperprolactinemia (MESH:D006966), lesion (MESH:D009059), bleeding (MESH:D006470), CSF leakage (MESH:D019585), pseudoaneurysm of the ICA (MESH:D020212), blindness (MESH:D001766), mass (MESH:C536030), Postoperative vasospasm (MESH:D020301), ischemia (MESH:D007511), neurological deficit (MESH:D009461), acute neurological disease (MESH:D000208), corticotrope pituitary neuroendocrine tumor (MESH:D018358), cerebellar defect (MESH:D002526), foot drop (MESH:D020427), craniopharyngioma (MESH:D003397), hypothalamic damage (MESH:D007027), loss of vision (MESH:D014786), disease (MESH:D004194), headache (MESH:D006261), dilated left pupil (MESH:C565277), arginine vasopressin deficiency (MESH:D020790), arterial vasospasm (MESH:D003329), meningitis (MESH:D008580), hyponatremia (MESH:D007010), neuroinflammation (MESH:D000090862), pituitary adenomas (MESH:D010911), behavioral abnormalities (MESH:D001523), rupture (MESH:D012421), cerebral ischemia (MESH:D002545), neurogenic voiding dysfunction (MESH:D001750), Tumor (MESH:D009369), pneumocephalus (MESH:D011007), heart disease (MESH:D006331), intracranial hypertension (MESH:D019586), infarction (MESH:D007238), neurological deterioration (MESH:D009422), tuberculum sellae meningiomas (MESH:D004652), visual field defects (MESH:D005128), meningioma (MESH:D008579), pituitary insufficiency (MESH:D007018), hypertension (MESH:D006973), aneurysmal subarachnoid hemorrhage (MESH:D013345), urinary retention (MESH:D016055), MCA infarct (MESH:D020244), Rathke's cleft cysts (MESH:D020863), pituitary macroadenoma (MESH:D010900), tumor bed (MESH:D003668), thrombosis (MESH:D013927), numbness (MESH:D006987), hemiparesis (MESH:D010291), aphasia (MESH:D001037), pituitary apoplexy (MESH:D010899), postoperative complication (MESH:D011183), skull base lesion (MESH:D019292)
- **Chemicals:** ASA (MESH:D001241), papaverine (MESH:D010208), prasugrel (MESH:D000068799), nicardipine (MESH:D009529), hydrocortisone (MESH:D006854), nifedipine (MESH:D009543), nimodipine (MESH:D009553), steroids (MESH:D013256), verapamil (MESH:D014700), milrinone (MESH:D020105), H (MESH:D006859), heparin (MESH:D006493), fasudil (MESH:C049347), Antiplatelet medication (-)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920372/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920372/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920372/full.md

---
Source: https://tomesphere.com/paper/PMC12920372